Skip to main content
رجوع
HSIC logo

Henry Schein, Inc.

جودة البيانات: 100%
HSIC
NASDAQ Healthcare Medical - Distribution
KWD 74.25
▲ KWD 0.23 (0.31%)
القيمة السوقية: 8.74B
نطاق اليوم
KWD 72.82 KWD 75.11
نطاق 52 أسبوعًا
KWD 60.56 KWD 89.29
حجم التداول
804,477
متوسط 50 يوم / 200 يوم
KWD 77.69 / KWD 72.09
الإغلاق السابق
KWD 74.02

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 22.0 0.3
P/B 2.7 3.0
ROE % 12.0 3.7
Net Margin % 3.0 3.8
Rev Growth 5Y % 1.5 10.0
D/E 1.1 0.2

السعر المستهدف للمحللين

Hold
KWD 90.17 +21.4%
Low: KWD 81.00 High: KWD 100.00
مكرر الربحية المستقبلي
14.03
ربحية السهم المستقبلية
KWD 5.29
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
13.72B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 6.80
KWD 6.75 – KWD 6.85
15.30B 1
FY2028 KWD 6.42
KWD 5.75 – KWD 6.93
14.72B 5
FY2027 KWD 5.84
KWD 5.71 – KWD 6.05
14.22B 10

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-24 KWD 1.30 KWD 1.34 +3.1%
2025-11-04 KWD 1.27 KWD 1.38 +8.7%
2025-08-05 KWD 1.18 KWD 1.10 -6.8%
2025-05-05 KWD 1.11 KWD 1.15 +3.6%
2025-02-25 KWD 1.23 KWD 1.19 -3.3%
2024-11-05 KWD 1.16 KWD 1.22 +5.2%
2024-08-06 KWD 1.22 KWD 1.23 +0.8%
2024-05-07 KWD 1.02 KWD 1.10 +7.8%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 1.54% annually over 5 years — modest growth
ROE of 11.99% — decent returns on equity
Generating 573.00M in free cash flow
Cash machine — converts 143.97% of earnings into free cash flow
Capital efficient — spends only 1.05% of revenue on capex

النمو

Revenue Growth (5Y)
1.54%
Revenue (1Y)4.03%
Earnings (1Y)2.05%
FCF Growth (3Y)27.41%

الجودة

Return on Equity
11.99%
ROIC8.20%
Net Margin3.02%
Op. Margin5.75%

الأمان

Debt / Equity
1.14
Current Ratio1.38
Interest Coverage5.05

التقييم

P/E Ratio
21.96
Forward P/E14.03
P/B Ratio2.69
EV/EBITDA16.19
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 4.03% Revenue Growth (3Y) 3.37%
Earnings Growth (1Y) 2.05% Earnings Growth (3Y) -2.19%
Revenue Growth (5Y) 1.54% Earnings Growth (5Y) -10.63%
Profitability
Revenue (TTM) 13.18B Net Income (TTM) 398.00M
ROE 11.99% ROA 3.55%
Gross Margin 29.14% Operating Margin 5.75%
Net Margin 3.02% Free Cash Flow (TTM) 573.00M
ROIC 8.20% FCF Growth (3Y) 27.41%
Safety
Debt / Equity 1.14 Current Ratio 1.38
Interest Coverage 5.05
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 21.96 Forward P/E 14.03
P/B Ratio 2.69 P/S Ratio 0.66
PEG Ratio 3.22 Forward PEG N/A
EV/EBITDA 16.19 Fwd EV/EBITDA 11.62
Forward P/S 0.64 Fwd Earnings Yield 7.13%
FCF Yield 6.56%
Market Cap 8.74B Enterprise Value 12.27B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13.18B 12.67B 12.34B 12.65B 12.40B
Net Income 398.00M 390.00M 416.00M 538.00M 623.91M
EPS (Diluted) 3.27 3.05 3.16 3.91 4.45
Gross Profit 3.84B 3.77B 3.65B 3.65B 3.67B
Operating Income 758.00M 729.00M 714.00M 938.00M 854.81M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 11.22B 10.22B 10.57B 8.61B 8.48B
Total Liabilities 6.42B 5.38B 5.42B 3.94B 3.81B
Shareholders' Equity 3.25B 3.39B 3.66B 3.45B 3.43B
Total Debt 3.69B 2.87B 2.74B 1.50B 1.22B
Cash & Equivalents 156.00M 122.00M 171.00M 117.00M 118.00M
Current Assets 4.46B 3.98B 4.49B 3.99B 3.84B
Current Liabilities 3.23B 2.80B 2.68B 2.22B 2.31B